ES2196952B1 - KIT FOR HYPERSENSITIVITY DIAGNOSIS AGAINST ALLERGENS OF THE OLIVE POLLEN AND ITS USE. - Google Patents

KIT FOR HYPERSENSITIVITY DIAGNOSIS AGAINST ALLERGENS OF THE OLIVE POLLEN AND ITS USE.

Info

Publication number
ES2196952B1
ES2196952B1 ES200100995A ES200100995A ES2196952B1 ES 2196952 B1 ES2196952 B1 ES 2196952B1 ES 200100995 A ES200100995 A ES 200100995A ES 200100995 A ES200100995 A ES 200100995A ES 2196952 B1 ES2196952 B1 ES 2196952B1
Authority
ES
Spain
Prior art keywords
kit
olive
pollen
allergens
hypersensitivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200100995A
Other languages
Spanish (es)
Other versions
ES2196952A1 (en
Inventor
Juan De Dios Alche Ramirez
Maria Isabel Rodriguez Garcia
Antonio Castro Lopez
Victor Alche Ramirez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOSPITAL GENERAL BASICO DE BAZ
HOSPITAL GENERAL BASICO DE BAZA
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
HOSPITAL GENERAL BASICO DE BAZ
HOSPITAL GENERAL BASICO DE BAZA
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOSPITAL GENERAL BASICO DE BAZ, HOSPITAL GENERAL BASICO DE BAZA, Consejo Superior de Investigaciones Cientificas CSIC filed Critical HOSPITAL GENERAL BASICO DE BAZ
Priority to ES200100995A priority Critical patent/ES2196952B1/en
Publication of ES2196952A1 publication Critical patent/ES2196952A1/en
Application granted granted Critical
Publication of ES2196952B1 publication Critical patent/ES2196952B1/en
Priority to ES200600090A priority patent/ES2326399B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Abstract

Kit para el diagnóstico de hipersensibilidad frente a alergenos del polen del olivo y su utilización. Este kit incluye una mezcla de extractos de polen procedentes de diversas variedades del olivo (Olea europaea), de acebuche, y de otros miembros de la familia Oleaceae (Fraxinus, Ligustrum, Phillyrea, Forsytia, Jasminum, Syringa), escogidas específicamente entre las variedades de un área geográfica. La mezcla de polen puede presentarse en forma de extractos crudos, purificados, adsorbidos o modificados, en soluciones acuosas, oleosas, depot, polimerizadas etc., o como mezclas con alergenos de otras fuentes.Kit for the diagnosis of hypersensitivity to allergens of olive pollen and its use. This kit includes a mixture of pollen extracts from various varieties of olive (Olea europaea), olive, and other members of the Oleaceae family (Fraxinus, Ligustrum, Phillyrea, Forsytia, Jasminum, Syringa), specifically chosen from the varieties of a geographical area. The pollen mixture can be presented in the form of crude, purified, adsorbed or modified extracts, in aqueous, oily, depot, polymerized solutions etc., or as mixtures with allergens from other sources.

ES200100995A 2001-04-27 2001-04-27 KIT FOR HYPERSENSITIVITY DIAGNOSIS AGAINST ALLERGENS OF THE OLIVE POLLEN AND ITS USE. Expired - Fee Related ES2196952B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES200100995A ES2196952B1 (en) 2001-04-27 2001-04-27 KIT FOR HYPERSENSITIVITY DIAGNOSIS AGAINST ALLERGENS OF THE OLIVE POLLEN AND ITS USE.
ES200600090A ES2326399B1 (en) 2001-04-27 2006-01-13 IMPROVEMENTS INTRODUCED IN THE OBJECT OF THE SPANISH PATENT APPLICATION N. P200100995 BY "KIT FOR THE HYPERSENSITIVITY DIAGNOSIS AGAINST ALLERGENS OF THE OLIVE POLLEN AND ITS USE".

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200100995A ES2196952B1 (en) 2001-04-27 2001-04-27 KIT FOR HYPERSENSITIVITY DIAGNOSIS AGAINST ALLERGENS OF THE OLIVE POLLEN AND ITS USE.

Publications (2)

Publication Number Publication Date
ES2196952A1 ES2196952A1 (en) 2003-12-16
ES2196952B1 true ES2196952B1 (en) 2005-04-01

Family

ID=30470463

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200100995A Expired - Fee Related ES2196952B1 (en) 2001-04-27 2001-04-27 KIT FOR HYPERSENSITIVITY DIAGNOSIS AGAINST ALLERGENS OF THE OLIVE POLLEN AND ITS USE.
ES200600090A Expired - Fee Related ES2326399B1 (en) 2001-04-27 2006-01-13 IMPROVEMENTS INTRODUCED IN THE OBJECT OF THE SPANISH PATENT APPLICATION N. P200100995 BY "KIT FOR THE HYPERSENSITIVITY DIAGNOSIS AGAINST ALLERGENS OF THE OLIVE POLLEN AND ITS USE".

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES200600090A Expired - Fee Related ES2326399B1 (en) 2001-04-27 2006-01-13 IMPROVEMENTS INTRODUCED IN THE OBJECT OF THE SPANISH PATENT APPLICATION N. P200100995 BY "KIT FOR THE HYPERSENSITIVITY DIAGNOSIS AGAINST ALLERGENS OF THE OLIVE POLLEN AND ITS USE".

Country Status (1)

Country Link
ES (2) ES2196952B1 (en)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
LICCARDI G. et al. Evaluation of serum specific IgE and skin responsiveness to allegenic extracts of Oleaceae pollens (Olea europaea, Fraxinus excelsior and Ligustrum vulgare) in patients with respiratory allergy. Allergologia et Immunopathologia, 1995, Vol. 23, nº 1, páginas 41-46. *
PAJARON M.J. et al. Cross-reactivity of Olea europaea with other Oleaceae species in allergic rhinitis and bronchial asthma. Allergy, 1997, Vol. 52, nº 8, páginas 829-835. *
WAISEL Y. et al. Antigenicity of the pollen proteins of various cultivars of Olea europaea. Allergy, 1996, Vol. 51, nº 11, páginas 819-825. *
WAISEL Y. et al. Reliability of olive pollen extracts for skin prick tests. The Journal of Allergy and Clinical Immunology, 1996, Vol. 98, nº 3, páginas 715-716. *

Also Published As

Publication number Publication date
ES2196952A1 (en) 2003-12-16
ES2326399B1 (en) 2010-07-06
ES2326399A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
AR054255A1 (en) TREATMENT OF INTESTINAL DYSFUNCTION IN HIV PATIENTS
UY28933A1 (en) COMBINATIONS THAT INCLUDE ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS
AR054122A1 (en) PIRIDO [2,3-D] USEFUL PYRIMIDES AS HCV INHIBITORS, AND METHODS FOR THE PREPARATION OF THE SAME
CL2007000361A1 (en) A combination comprising an inhibitor of the hepatitis c virus (vhc) arn polymerase and a vhc protease inhibitor; pharmaceutical composition that includes it; and use of the combination to treat disorders associated with vhc.
HN2002000275A (en) DERIVATIVES OF 1.8 NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS
CL2008002207A1 (en) Pharmaceutical composition comprising immunosuppressants to improve the effect in the use of an antagonist of interleukin-6 (il-6) for the treatment of illnesses related to il-6 (div. Sol. 896-04).
CL2007001665A1 (en) Antibody or fragment thereof with neutralizing activity of protein nr 10; agent who understands it; and its use to prevent or treat an inflammatory disease.
GT200500007A (en) [1,8] NAFTIRIDIN-2-WAVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA.
CO6180433A2 (en) LINGO LINK MOLECULES AND PHARMACEUTICAL USE OF THE SAME
NI200700056A (en) NEW DERIVATIVES OF SULFAMIDS OF HETEROARIL BENZO-FUNDIDO USEFUL AS ANTI-CONVERSION AGENTS
CR8858A (en) SULFAMATE AND SULFAMIDE DERIVATIVES FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS
AR059330A1 (en) HAIR CONDITIONING COMPOSITIONS
CO5660275A2 (en) COMPOSITION THAT INCLUDES A PDE4 INHIBITOR AND A PDE5 INHIBITOR
UY29236A1 (en) 2-ALCOXI-3,4,5-TRIHIDROXI-ALQUILAMIDAS. ITS PREPARATION, COMPOSITIONS THAT CONTAIN THEM AND ITS USE.
BRPI0510938A (en) Vitamin K1 as Energizer in Cosmetic Formulations
UY28312A1 (en) REPLACED PIRAZOLOPIRIMIDINES WITH 6-CYCLIMETY AND 6-RENT
AR066067A1 (en) PAD FOR CLEANING HARD SURFACES
SV2006002384A (en) PIRAZOLO PIRIDINAS REPLACED, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCEDURE
CL2008002082A1 (en) Compounds derived from 6-phenyl-1h-imidazo [4,5-c] pyridine-4-carbonitrile, inhibitors of cathepsin s and cathepsin k; pharmaceutical composition; and use in the treatment of osteoporosis, atherosclerosis, inflammation, among other diseases.
UY27203A1 (en) USEFUL BENCIMIDAZOLS IN THE TREATMENT OF SEXUAL DYSFUNCTION
AR056749A1 (en) ORGANOLEPTICALLY ORGANOLEPTICALLY ACCEPTABLE IBUPROPHEN DOSAGE FORMULATIONS METHODS FOR PREPARATION AND USE
CL2004000535A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES RAPAMYCIN OR A DERIVATIVE OF RAPAMYCIN AND PIMECROLIMUS; AND ITS USE FOR THE TREATMENT OF INFLAMMATORY DISEASE OF THE INTESTINE.
ES2196952B1 (en) KIT FOR HYPERSENSITIVITY DIAGNOSIS AGAINST ALLERGENS OF THE OLIVE POLLEN AND ITS USE.
ATE399558T1 (en) ANTI-TUMORAL FORMULATIONS CONTAINING DEFIBROTIDE ALONE OR IN COMBINATION WITH OTHER ANTITUMORAL AGENTS
CL2010001594A1 (en) Use of nifurtimox to prepare a medicine useful in the treatment of diseases caused by trichomonadide.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20031216

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2196952B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20190521

FD2A Announcement of lapse in spain

Effective date: 20190604